WallStreetZenWallStreetZen

NYSE: UPH
Uphealth Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for UPH

Based on 3 analysts offering 12 month price targets for Uphealth Inc.
Min Forecast
$1.00+88.68%
Avg Forecast
$3.17+497.55%
Max Forecast
$4.50+749.06%

Should I buy or sell UPH stock?

Based on 3 analysts offering ratings for Uphealth Inc.
Buy
Strong Buy
1 analysts 33.33%
Buy
1 analysts 33.33%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their UPH stock forecasts and price targets.

UPH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Benchmark
Top 5%
96
Strong BuyMaintains$4.00+654.72%2022-05-13
Lake Street
Bottom 3%
3
HoldDowngrades$1.00+88.68%2022-03-31
Northland Securities
Bottom 4%
4
BuyMaintains$4.50+749.06%2022-03-31

1 of 1

Forecast return on equity

Is UPH forecast to generate an efficient return?
Company
0.51%
Industry
11.97%
Market
118.57%
UPH's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is UPH forecast to generate an efficient return on assets?
Company
0.28%
Industry
8.18%
UPH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

UPH earnings per share forecast

What is UPH's earnings per share in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$0.26
Avg 2 year Forecast
-$0.14
Avg 3 year Forecast
-$0.08

UPH revenue forecast

What is UPH's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$193.1M+21.65%
Avg 2 year Forecast
$253.0M+59.37%
Avg 3 year Forecast
$335.2M+111.17%
UPH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

UPH revenue growth forecast

How is UPH forecast to perform vs Health Information Services companies and vs the US market?
Company
27.48%
Industry
14.67%
Market
8.46%
UPH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
UPH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

UPH vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
UPH$0.53$3.17+497.55%Buy
SY$0.74$9.00+1,124.49%Buy
MSPR$1.21N/AN/A
MTBC$4.42$11.00+148.87%Strong Buy
ICAD$2.25$9.75+333.33%Buy

Uphealth Stock Forecast FAQ

Is Uphealth Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NYSE: UPH) stock is to Buy UPH stock.

Out of 3 analysts, 1 (33.33%) are recommending UPH as a Strong Buy, 1 (33.33%) are recommending UPH as a Buy, 1 (33.33%) are recommending UPH as a Hold, 0 (0%) are recommending UPH as a Sell, and 0 (0%) are recommending UPH as a Strong Sell.

If you're new to stock investing, here's how to buy Uphealth stock.

What is UPH's earnings growth forecast for 2022-2024?

(NYSE: UPH) Uphealth's forecast annual earnings growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 7.94%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 16.42%.

Uphealth's earnings in 2022 is -$335,173,000.On average, 2 Wall Street analysts forecast UPH's earnings for 2022 to be -$38,276,076, with the lowest UPH earnings forecast at -$47,109,016, and the highest UPH earnings forecast at -$30,915,292. On average, 2 Wall Street analysts forecast UPH's earnings for 2023 to be -$20,610,195, with the lowest UPH earnings forecast at -$20,610,195, and the highest UPH earnings forecast at -$19,138,038.

In 2024, UPH is forecast to generate -$11,777,254 in earnings, with the lowest earnings forecast at -$11,777,254 and the highest earnings forecast at -$11,777,254.

What is UPH's revenue growth forecast for 2022-2024?

(NYSE: UPH) Uphealth's forecast annual revenue growth rate of 27.48% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 14.67%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 8.46%.

Uphealth's revenue in 2022 is $158,737,000.On average, 2 Wall Street analysts forecast UPH's revenue for 2022 to be $28,428,818,999, with the lowest UPH revenue forecast at $26,646,037,175, and the highest UPH revenue forecast at $30,211,600,824. On average, 2 Wall Street analysts forecast UPH's revenue for 2023 to be $37,243,210,324, with the lowest UPH revenue forecast at $32,664,066,753, and the highest UPH revenue forecast at $41,822,501,111.

In 2024, UPH is forecast to generate $49,346,694,260 in revenue, with the lowest revenue forecast at $49,346,694,260 and the highest revenue forecast at $49,346,694,260.

What is UPH's forecast return on assets (ROA) for 2022-2025?

(NYSE: UPH) forecast ROA is 0.28%, which is lower than the forecast US Health Information Services industry average of 8.18%.

What is UPH's Price Target?

According to 3 Wall Street analysts that have issued a 1 year UPH price target, the average UPH price target is $3.17, with the highest UPH stock price forecast at $4.50 and the lowest UPH stock price forecast at $1.00.

On average, Wall Street analysts predict that Uphealth's share price could reach $3.17 by May 13, 2023. The average Uphealth stock price prediction forecasts a potential upside of 497.55% from the current UPH share price of $0.53.

What is UPH's Earnings Per Share (EPS) forecast for 2022-2024?

(NYSE: UPH) Uphealth's current Earnings Per Share (EPS) is -$3.09. On average, analysts forecast that UPH's EPS will be -$0.26 for 2022, with the lowest EPS forecast at -$0.32, and the highest EPS forecast at -$0.21. On average, analysts forecast that UPH's EPS will be -$0.14 for 2023, with the lowest EPS forecast at -$0.14, and the highest EPS forecast at -$0.13. In 2024, UPH's EPS is forecast to hit -$0.08 (min: -$0.08, max: -$0.08).

What is UPH's forecast return on equity (ROE) for 2022-2025?

(NYSE: UPH) forecast ROE is 0.51%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.